A phase II study of mitomycin-C and S-1 as third-line chemotherapy in patients with advanced colorectal cancer

By                          

Oncology Letters, Vol. 2, Iss. 6, 2011-01 ,pp. : 1253-1256

Spandidos Publications

Access to resources Recommend Favorite

Activity and safety of erlotinib as second- and third-line treatment in elderly patients with advanced non-small cell lung cancer: a phase II trial

By Rossi David  

Targeted Oncology, Vol. 5, Iss. 4, 2010-12 ,pp. : 231-235

Springer Publishing Company

Access to resources Recommend Favorite

A Phase II Multicenter Study of Two Different Dosages of Pemetrexed Given in Combination With Cyclophosphamide as First-Line Treatment in Patients With Locally Advanced or Metastatic Breast Cancer

By Dittrich Christian   Solska Ewa   Manikhas Alexey   Eniu Alexandru   Tjulandin Sergei   Anghel Rodica   Musib Luna   Frimodt-Moller Bente   Liu Yushan   Krejcy Kurt   Láng István  

Cancer Investigation, Vol. 30, Iss. 4, 2012-04 ,pp. : 309-316

Informa Healthcare

Access to resources Recommend Favorite

Comparison of Letrozole and Aminoglutethimide in Treatment of 113 Cases of Postmenopausal Women with Advanced Breast Cancer

By Liu Donggeng   Guan Zhongzhen   Shen Zhenzhou   Han Qixia   Song Santai   Liu Xiaoqing  

The Chinese-German Journal of Clinical Oncology, Vol. 3, Iss. 2, 2004-06 ,pp. : 90-92

Springer Publishing Company

Access to resources Recommend Favorite

Clinical Evaluation of the Use of Exemestane as Further Hormonal Therapy after Nonsteroidal Aromatase Inhibitors in Postmenopausal Metastatic Breast Cancer Patients

By Carlini Paolo   Michelotti Andrea   Ferretti Gianluigi   Ricci Sergio   Giannarelli Diana   Pellegrini Manuela   Cresti Nicola   Cosimo Serena Di   Bria Emilio   Papaldo Paola   Fabi Alessandra   Ruggeri Enzo Maria   Milella Michele   Alimonti Andrea   Salesi Nello   Cognetti Francesco  

Cancer Investigation, Vol. 25, Iss. 2, 2007-03 ,pp. : 102-105

Informa Healthcare

Access to resources Recommend Favorite